For instance, using data obtained from the GENIE v3 cohort, we observed that RAF1 amplifications occur in bladder tumors at a frequency of 3.8% (139 out of 3844 patients), a rate higher than that for RAF1 amplifications in any other tumor type within this cohort. The gene discussed is RAF1; the disease is neoplasm.